최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국콘텐츠학회논문지 = The Journal of the Korea Contents Association, v.18 no.12, 2018년, pp.208 - 217
The purpose of this study was to provide information on the treatment and management of diabetic patients using all the available data of the Korea National Health and Nutrition Examination Survey (KNHANES, 2013-2015) on the serological and complication patterns of cardiovascular disease (CVD) accor...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
만성적인 당뇨병 합병증의 특징은? | 한국은 점차 서구화된 생활양식으로 인해 지속적으로 비만율이 높아지면서 당뇨병이 증가하고 있어, 결과적으로 당뇨병 관련 이환율이 증가되어 사회 경제적 부담이 된다[1]. 만성적인 당뇨병 합병증에는 크고 작은 혈관 손상이 포함된다[2]. 관상동맥질환, 뇌졸중, 말초 동맥질환 및 심근병증과 같은 다양한 심혈관 관련 합병증이 있으며 사망에 이르게 한다[3]. | |
우리나라에서 당뇨병이 증가한 원인은 무엇인가? | 당뇨병은 서구 여러 나라와 아시아에서 최근 유병율이 증가하면서 경제, 사회, 보건학적으로 문제가 되고 있다. 한국은 점차 서구화된 생활양식으로 인해 지속적으로 비만율이 높아지면서 당뇨병이 증가하고 있어, 결과적으로 당뇨병 관련 이환율이 증가되어 사회 경제적 부담이 된다[1]. 만성적인 당뇨병 합병증에는 크고 작은 혈관 손상이 포함된다[2]. | |
만성적인 당뇨병 합병증의 종류에는 어떤 것들이 있나? | 만성적인 당뇨병 합병증에는 크고 작은 혈관 손상이 포함된다[2]. 관상동맥질환, 뇌졸중, 말초 동맥질환 및 심근병증과 같은 다양한 심혈관 관련 합병증이 있으며 사망에 이르게 한다[3]. 심혈관 질환 발병의 상대위험도는 일반인과 비교하여 당뇨병 환자의 경우 2배 높았으며 심혈관 질환은 시간이 지남에 따라 감소하지만 사망률은 유의하게 증가하였다[4]. |
J. A. Beckman, M. A. Creager, and P. Libby, "Diabetes and atherosclerosis: epidemiology, pathophysiology, and management," JAMA, Vol.287, No.19, pp.2570-2581, 2002.
J. Y. Jeon, S. H. Ko, H. S. Kwon, N. H. Kim, J. H. Kim, C. S. Kim, K. H. Song, J. C. Won, S. Lim, S. H. Choi, M. J. Jang, Y. Kim, K. Oh, D. J. Kim, B. Y. Cha, and A. Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes, "Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c," Diabetes Metab J, Vol.37, No.5, pp.349-357, 2013.
C. A. Reasner, "Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors," J Cardiovasc Pharmacol, Vol.52, No.2, pp.136-144, 2008.
S. Rao Kondapally Seshasai, S. Kaptoge, A. Thompson, E. Di Angelantonio, P. Gao, N. Sarwar, P. H. Whincup, K. J. Mukamal, R. F. Gillum, I. Holme, I. Njolstad, A. Fletcher, P. Nilsson, S. Lewington, R. Collins, V. Gudnason, S. G. Thompson, N. Sattar, E. Selvin, F. B. Hu, J. Danesh, and C. Emerging Risk Factors, "Diabetes mellitus, fasting glucose, and risk of cause-specific death," N Engl J Med, Vol.364, No.9, pp.829-841, 2011.
C. Centers for Disease and Prevention, "Prevalence of self-reported cardiovascular disease among persons aged > or 35 years with diabetes-United States, 1997-2005," MMWR Morb Mortal Wkly Rep, Vol.56, No.43, pp.1129-1132, 2007.
Korea National Health and Nutrition Examination Survey, https://knhanes.cdc.go.kr/knhanes/sub03/sub03_02_02.do
A. American Diabetes, "Standards of medical care in diabetes-2015 abridged for primary care providers," Clin Diabetes, Vol.33, No.2, pp.97-111, 2015.
P. A. James, S. Oparil, B. L. Carter, W. C. Cushman, C. Dennison-Himmelfarb, J. Handler, D. T. Lackland, M. L. LeFevre, T. D. MacKenzie, O. Ogedegbe, S. C. Smith Jr., L. P. Svetkey, S. J. Taler, R. R. Townsend, J. T. Wright Jr., A. S. Narva, and E. Ortiz, "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)," JAMA, Vol.311, No.5, pp.507-520, 2014.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)," JAMA, Vol.285, No.19, pp.2486-2497, 2001.
Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults, "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary," Am J Clin Nutr, Vol.68, No.4, pp.899-917, 1998.
E. J. Lamb, C. R. Tomson, P. J. Roderick, and B. Clinical Sciences Reviews Committee of the Association for Clinical, "Estimating kidney function in adults using formulae," Ann Clin Biochem, Vol.42, No.Pt 5, pp.321-345, 2005.
Korean Statistical Information Service, http://www.kosis.kr/statHtml/statHtml.do?orgId117&tblIdDT_11702_N102
R. Lajara, R. Aguilar, U. Hehnke, H. J. Woerle, and M. von Eynatten, "Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials," Clin Ther, Vol.36, No.11, pp.1595-1605, 2014.
E. Szoke, M. Z. Shrayyef, S. Messing, H. J. Woerle, T. W. van Haeften, C. Meyer, A. Mitrakou, W. Pimenta, and J. E. Gerich, "Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance," Diabetes Care, Vol.31, No.3, pp.539-543, 2008.
D. J. Margolis, O. Hoffstad, and B. L. Strom, "Association between serious ischemic cardiac outcomes and medications used to treat diabetes," Pharmacoepidemiol Drug Saf, Vol.17, No.8, pp.753-759, 2008.
J. M. Gamble, S. H. Simpson, D. T. Eurich, S. R. Majumdar, and J. A. Johnson, "Insulin use and increased risk of mortality in type 2 diabetes: a cohort study," Diabetes Obes Metab, Vol.12, No.1, pp.47-53, 2010.
V. Patney, A. Whaley-Connell, and G. Bakris, "Hypertension Management in Diabetic Kidney Disease," Diabetes Spectr, Vol.28, No.3, pp.175-180, 2015.
A. J. Hahr and M. E. Molitch, "Management of diabetes mellitus in patients with chronic kidney disease," Clin Diabetes Endocrinol, Vol.1, p.2, 2015.
D. Orozco-Beltran, V. F. Gil-Guillen, F. Quirce, J. Navarro-Perez, M. Pineda, A. Gomez-dela- Camara, S. Pita, J. Diez-Espino, J. Mateos, J. Merino, M. Serrano-Rios, and I. Collaborative Diabetes Study, "Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain," Int J Clin Pract, Vol.61, No.6, pp.909-915, 2007.
F. P. Schena and L. Gesualdo, "Pathogenetic mechanisms of diabetic nephropathy," Journal of the American Society of Nephrology, Vol.16, No.3, Suppl.1, pp.S30-S33, 2005.
M. J. Fowler, "Microvascular and macrovascular complications of diabetes," Clinical diabetes, Vol.26, No.2, pp.77-82, 2008.
A. I. Adler, R. J. Stevens, S. E. Manley, R. W. Bilous, C. A. Cull, R. R. Holman, and G. Ukpds, "Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)," Kidney Int, Vol.63, No.1, pp.225-232, 2003.
F. A. El-Atat, S. N. Stas, S. I. McFarlane, and J. R. Sowers, "The relationship between hyperinsulinemia, hypertension and progressive renal disease," Journal of the American Society of Nephrology, Vol.15, No.11, pp.2816-2827, 2004.
P. J. Boyle, "Diabetes mellitus and macrovascular disease: mechanisms and mediators," Am J Med, Vol.120, No.9, Suppl.2, pp.S12-17, 2007.
M. Sakamoto, "Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice," J Clin Med Res, Vol.10, No.10, pp.737-742, 2018.
M. Brownlee, "Glycation products and the pathogenesis of diabetic complications," Diabetes Care, Vol.15, No.12, pp.1835-1843, 1992.
L. E. Garcia-Perez, M. Alvarez, T. Dilla, V. Gil-Guillen, and D. Orozco-Beltran, "Adherence to therapies in patients with type 2 diabetes," Diabetes Ther, Vol.4, No.2, pp.175-194, 2013.
R. Boussageon, T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, B. Kassai, S. Erpeldinger, J. M. Wright, F. Gueyffier, and C. Cornu, "Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: metaanalysis of randomised controlled trials," BMJ, Vol.343, p.d4169, 2011.
W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, P. D. Reaven, F. J. Zieve, J. Marks, S. N. Davis, R. Hayward, S. R. Warren, S. Goldman, M. McCarren, M. E. Vitek, W. G. Henderson, G. D. Huang, and V. Investigators, "Glucose control and vascular complications in veterans with type 2 diabetes," N Engl J Med, Vol.360, No.2, pp.129-139, 2009.
F. B. Hu, M. J. Stampfer, C. G. Solomon, S. Liu, W. C. Willett, F. E. Speizer, D. M. Nathan, and J. E. Manson, "The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up," Archives of internal medicine, Vol.161, No.14, pp.1717-1723, 2001.
W. B. Kannel, "Lipids, diabetes, and coronary heart disease: insights from the Framingham Study," Am Heart J, Vol.110, No.5, pp.1100-1107, 1985.
R. M. Krauss and P. W. Siri, "Dyslipidemia in type 2 diabetes," Med Clin North Am, Vol.88, No.4, pp.897-909, 2004.
S. Natarajan, Y. Liao, D. Sinha, G. Cao, D. L. McGee, and S. R. Lipsitz, "Sex differences in the effect of diabetes duration on coronary heart disease mortality," Arch Intern Med, Vol.165, No.4, pp.430-435, 2005.
S. G. Wannamethee, A. G. Shaper, P. H. Whincup, L. Lennon, and N. Sattar, "Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors," Arch Intern Med, Vol.171, No.5, pp.404-410, 2011.
E. B. Schroeder, L. E. Chambless, D. Liao, R. J. Prineas, G. W. Evans, W. D. Rosamond, G. Heiss, and S. Atherosclerosis Risk in Communities, "Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study," Diabetes Care, Vol.28, No.3, pp.668-674, 2005.
A. Gottsater, A. R. Ahlgren, S. Taimour, and G. Sundkvist, "Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes," Clin Auton Res, Vol.16, No.3, pp.228-234, 2006.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.